医疗设备集采如何实现三方共赢

Core Viewpoint - The phenomenon of "ultra-low price bidding" in medical device procurement is raising concerns about potential hidden waste and increased financial burden, prompting the National Healthcare Security Administration to clarify that procurement will no longer solely rely on the lowest price as a reference [1][3]. Group 1: Impact of Low Price Bidding - The aim of centralized procurement is to eliminate price inflation and ensure efficient use of fiscal funds, but the frequent occurrence of "ultra-low price bidding" may lead to hidden waste and increased financial burdens [3][5]. - The strategy of "lowest price wins" can force companies to cut core configurations, use lower-grade components, or compromise quality control, leading to wasted resources and equipment that may be unusable [3][5]. - Reports indicate that some grassroots hospitals have a medical device usage rate of less than 40%, often due to rigid procurement practices that prioritize low prices over quality, resulting in poor performance or complex operations that lead to abandonment [3][5]. Group 2: Long-term Industry Consequences - The long-term harm of the "lowest price" strategy to the medical device industry is significant, as companies may resort to extreme low pricing to survive, undermining the industry's pricing structure and stifling innovation [5][6]. - Continuous low-price competition is depleting the industry's capacity for innovation and may ultimately harm product quality and healthcare service levels, hindering the industry's transition to higher-end development [5][6]. - This short-sighted strategy can lead to a "technical disconnection," where the industry loses its ability to advance technologically and maintain future competitiveness [5][6]. Group 3: Quality and Service in Procurement - The quality of low-priced devices is often questionable, with issues such as poor image quality, insufficient diagnostic accuracy, and missing functions, which can jeopardize patient health [7][9]. - To address the challenges posed by the "lowest price" approach, establishing a "quality for price" orientation has become a core concern of procurement policy, with ongoing efforts to optimize mechanisms at the national level [7][9]. - The characteristics of "good devices" needed in procurement are becoming clearer, focusing on superior quality performance, excellent clinical adaptability, and a reliable after-sales service system [9][10]. Group 4: Industry Innovation and Future Outlook - Leading companies in the industry are accelerating innovation around these standards, utilizing AI algorithms to optimize manufacturing processes and enhance product quality and service capabilities [10]. - Future procurement will favor manufacturers that can meet stringent quality performance standards, accurately match diverse clinical needs, and provide reliable long-term after-sales support [10].